Lin et al., 2011 [28] | Myocardial infarction | Psoriasis: 4752; Controls: 23,760 | Hazard ratio: 2.10 (95% CI 1.27 - 3.43) | Taiwan/Retrospective cohort study |
Mallbris et al., 2004 [58] | Cardiovascular mortality | Psoriasis inpatients: 8991; Psoriasis outpatients: 19,757 | Standardized mortality ratio: Inpatients: 1.52 (95% CI 1.44 - 1.60); Outpatients: 0.94 (95% CI 0.89 - 0.99) | Sweden/Cohort study |
Mehta et al., 2010 [16] | Cardiovascular mortality | Severe psoriasis: 3603; Controls: 14,330 | Hazard ratio: 1.57 (95% CI 1.26 - 1.96) | United Kingdom/Cohort study |
Ogdie et al., 2015 [23] | Major adverse cardiovascular events (including myocardial infarction, cerebrovascular accidents and cardiovascular death) | Psoriasis: 138,424; Controls: 81,573 | Hazard ratio: Mild psoriasis (no DMARD): 1.08 (95% CI 1.02 - 1.15); Severe psoriasis (DMARD user): 1.42 (95% CI 1.17 - 1.73) | United Kingdom/Cohort study |
Prodanovich et al., 2009 [40] | Ischemic heart disease; Cerebrovascular disease; Peripheral vascular disease | Psoriasis: 3236; Controls: 2500 | Odds ratio: Ischemic heart disease: 1.78 (95% CI 1.51 - 2.11); Cerebrovascular disease: 1.70 (95% CI 1.33 - 2.17); Peripheral vascular disease: 1.98 (95% CI 1.38 - 2.82) | United States/Observational cross-sectional study |
Shiba et al., 2016 [29] | Coronary heart disease | Hospital-based population: 113,065; Psoriasis: 1197 | Odds ratio: 1.27 (95% CI 1.01 - 1.58) | Japan/Cross-sectional study |
Stern et al., 2011 [31] | Cardiovascular mortality | Severe psoriasis: 1376 | Standard mortality ratio: 1.02 (95% CI 0.90 - 1.16) | United States/Prospective cohort study |
Wakkee et al., 2010 [32] | Ischemic heart disease hospitalization | Psoriasis: 15,820; Controls: 27,577 | Hazard ratio: 1.05 (95% CI 0.95 - 1.17) | Netherlands/Cohort study |
Wu et al., 2015 [24] | Myocardial infarction | Mild psoriasis: 10,173 (controls: 50,865); Severe psoriasis: 3841 (controls: 19,205) | Hazard ratio: Mild psoriasis: 1.31 (95% CI 1.14 - 1.51); Severe psoriasis: 1.28 (95% CI 1.02 - 1.60) | United States/Retrospective cohort study |